|Common Stock Symbol||GAM|
|Preferred Stock Symbol||GAM Pr b|
|Common Stock Cusip||368802104|
|Preferred Stock Cusip||368802401|
|Quarter Ended Data 03/31/2013|
|Common Closing Price||$31.23|
|Preferred Liquidation Preference||$25.00|
|Preferred Closing Price||$25.57|
|Net Assets - Common||$1,066.9 mil.|
|Liquidation Value - Preferred||$190.1 mil.|
Since March 1995, the Board of Directors has authorized the repurchase of Common Stock in the open market when the shares trade at a discount to net asset value of at least 8%. Through March 31, 2013, the Company has repurchased a total of 18.2 million shares of Common Stock at a total cost of $503.7 million. During the three months ended March 31, 2013, 6,366 shares of Common Stock were repurchased at a cost of $197,952, a discount of 13.0% to net asset value.
|GAM Stockholder Return
|GAM Net Asset
|Standard & Poor's 500
Stock Index Return*
|Industry Sector||% Common Net Assets*|
|Health Care/Pharmaceuticals, Biotechnology & Life Sciences||5.7|
|Total Long-Term Investments||106.2|
|Cash, equivalents, receivables and other assets less liabilities||11.6|
|Preferred Stock, at liquidation value||-17.8|
|Total Net Assets Applicable to Common Stock||100.0|
The TJX Companies, Inc.
Diaego plc ADR
Arch Capital Group Ltd.
Costco Wholesale Corporation
Republic Services, Inc.
Everest Re Group, Ltd.